1. |
Singh SI, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations. Eur Respir Rev, 2014, 23(131): 149-152.
|
2. |
Reddy A, Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract, 2017, 5(3): 866-867.
|
3. |
中华医学会呼吸病学分会哮喘学组. 变应性支气管肺曲霉病诊治专家共识. 中华医学杂志, 2017, 97(34): 2650-2656.
|
4. |
Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 2008, 46(3): 327-360.
|
5. |
任少华, 胡华成. 变态反应性支气管-肺烟曲菌病的临床研究进展. 中国呼吸与危重监护杂志, 2003, 2(5): 62-64.
|
6. |
马艳良, 张为兵, 余兵, 等. 支气管哮喘患者中变应性支气管肺曲霉病的检出及临床特点初步调查. 中华结核和呼吸杂志, 2011, 34(12): 909-913.
|
7. |
Agarwal R, Aggarwal AN, Gupta D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis, 2009, 13(8): 936-944.
|
8. |
Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy, 2013, 43(8): 850-873.
|
9. |
Sunzini F, Barbato C, Canofari C, et al. Clinical and radiological signs of ABPA associated with airways infection with Aspergillus in the absence of specific IgE. Eur Ann Allergy Clin Immunol, 2016, 48(5): 202-204.
|
10. |
Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med, 1991, 117(2): 138-142.
|
11. |
陆海雯, 卫平, 徐金富. 变应性支气管肺曲霉病的诊断标准变迁及影像学分类进展. 中国呼吸与危重监护杂志, 2014, 13(5): 534-536.
|
12. |
Agarwal R, Khan A, Garg M, et al. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol, 2012, 4(4): 141-150.
|
13. |
Agarwal R. Allergic bronchopulmonary aspergillosis. Chest, 2009, 135(3): 805-826.
|
14. |
Moss RB. Treating allergic bronchopulmonary aspergillosis: the way forward. Eur Respir J, 2016, 47(2): 385-387.
|
15. |
Agarwal R, Aggarwal AN, Dhooria S, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J, 2016, 47(2): 490-498.
|
16. |
Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev, 2018, 3: D10288.
|
17. |
Leon EE, Craig TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol, 1999, 82(6): 511-516.
|
18. |
Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol, 2008, 43(6): 607-610.
|
19. |
Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med, 2010, 104(2): 204-210.
|